Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INDV

Indivior (INDV)

Indivior PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INDV
DateTimeSourceHeadlineSymbolCompany
05/23/20248:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
05/23/20246:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
05/23/20246:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
05/22/20245:14AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
05/21/20245:11AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
05/20/20249:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
05/13/20247:28AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
05/09/202410:49AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
05/09/20245:22AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
04/25/20241:00AMPR Newswire (US)Indivior Announces Q1 2024 Financial ResultsNASDAQ:INDVIndivior PLC
03/11/20241:43PMPR Newswire (US)Indivior Announces Publication Demonstrating that OPVEEĀ® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal NaloxoneNASDAQ:INDVIndivior PLC
02/29/20241:02AMPR Newswire (US)Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict LitigationNASDAQ:INDVIndivior PLC
02/22/20241:00AMPR Newswire (US)Indivior Announces Q4 / FY 2023 Financial ResultsNASDAQ:INDVIndivior PLC
11/09/20231:05AMPR Newswire (US)Indivior Announces Q3 2023 Financial ResultsNASDAQ:INDVIndivior PLC
11/09/20231:05AMPR Newswire (US)Indivior Announces Q3 2023 Financial ResultsNASDAQ:INDVIndivior PLC
10/11/20233:20PMPR Newswire (US)Indivior Enters an Exclusive Licensing Agreement with Alar PharmaceuticalsNASDAQ:INDVIndivior PLC
09/26/20231:30PMPR Newswire (US)Indivior Publishes Real World Data Showing SUBLOCADEĀ® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in CanadaNASDAQ:INDVIndivior PLC
08/21/20231:02AMPR Newswire (US)Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation ClaimsNASDAQ:INDVIndivior PLC
08/21/20231:02AMPR Newswire (US)Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation ClaimsNASDAQ:INDVIndivior PLC
07/27/20231:00AMPR Newswire (US)Indivior Announces Q2/H1 2023 Financial ResultsNASDAQ:INDVIndivior PLC
06/14/202312:53PMPR Newswire (US)Indivior Announces Four Abstracts Accepted for Presentation at the 85th Annual Scientific Meeting of the College on Problems of Drug DependenceNASDAQ:INDVIndivior PLC
 Showing the most relevant articles for your search:NASDAQ:INDV